Early diagnosis and treatment of renal cell carcinoma of native kidney in kidney transplantation
Diagnóstico y tratamiento precoz del carcinoma renal de riñón nativo en trasplante renal
Read
10462
Timeswas read the article
2683
Total PDF
7779
Total HTML
Share statistics
array:21 [ "pii" => "X2013251411052537" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Jun.10929" "estado" => "S300" "fechaPublicacion" => "2011-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:567-72" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5498 "formatos" => array:3 [ "EPUB" => 309 "HTML" => 4494 "PDF" => 695 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X021169951105253X" "issn" => "02116995" "doi" => "10.3265/Nefrologia.pre2011.Jun.10929" "estado" => "S300" "fechaPublicacion" => "2011-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2011;31:567-72" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 13454 "formatos" => array:3 [ "EPUB" => 316 "HTML" => 12424 "PDF" => 714 ] ] "es" => array:12 [ "idiomaDefecto" => true "titulo" => "Diagnóstico y tratamiento precoz del carcinoma renal de riñón nativo en trasplante renal" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "567" "paginaFinal" => "572" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Early diagnosis and treatment of renal cell carcinoma of native kidney in kidney transplantation" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "10929_108_16005_es_10929_t1..jpg" "Alto" => 384 "Ancho" => 600 "Tamanyo" => 195471 ] ] "descripcion" => array:1 [ "es" => "Características de los pacientes" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "T. García Álvarez, A. Mazuecos Blanca, N. Navas García, L. Calle García, E. Vallejos Roca, A. Moreno Salazar, J. Soto Villalba, R. Collantes Mateos, M. Rivero Sánchez" "autores" => array:9 [ 0 => array:2 [ "Iniciales" => "T." "apellidos" => "García Álvarez" ] 1 => array:2 [ "Iniciales" => "A." "apellidos" => "Mazuecos Blanca" ] 2 => array:2 [ "Iniciales" => "N." "apellidos" => "Navas García" ] 3 => array:2 [ "Iniciales" => "L." "apellidos" => "Calle García" ] 4 => array:2 [ "Iniciales" => "E." "apellidos" => "Vallejos Roca" ] 5 => array:2 [ "Iniciales" => "A." "apellidos" => "Moreno Salazar" ] 6 => array:2 [ "Iniciales" => "J." "apellidos" => "Soto Villalba" ] 7 => array:2 [ "Iniciales" => "R." "apellidos" => "Collantes Mateos" ] 8 => array:2 [ "Iniciales" => "M." "apellidos" => "Rivero Sánchez" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251411052537" "doi" => "10.3265/Nefrologia.pre2011.Jun.10929" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411052537?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169951105253X?idApp=UINPBA000064" "url" => "/02116995/0000003100000005/v0_201502091408/X021169951105253X/v0_201502091409/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X2013251411052529" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Jul.10893" "estado" => "S300" "fechaPublicacion" => "2011-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:573-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4984 "formatos" => array:3 [ "EPUB" => 297 "HTML" => 4064 "PDF" => 623 ] ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "Diagnostic efficiency of a hyperbolic model in predicting digoxin concentrations based on glomerular filtration rates" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "573" "paginaFinal" => "578" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Eficiencia diagnóstica de la predicción de concentraciones de digoxina en función de la tasa de filtración glomerular mediante un modelo hiperbólico" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "10893_108_21688_en_f110893.jpg" "Alto" => 1335 "Ancho" => 600 "Tamanyo" => 255536 ] ] "descripcion" => array:1 [ "en" => "Correlation between glomerular filtration rate and obtained digoxin concentration (A), digoxin clearance (B) and the ratio (digoxin clearance) / (glomerular filtration rate)." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Jaime Gonzalez-López, J. González-López, José Carlos Tutor, J.C. Tutor" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Jaime" "apellidos" => "Gonzalez-López" ] 1 => array:2 [ "Iniciales" => "J." "apellidos" => "González-López" ] 2 => array:2 [ "nombre" => "José Carlos" "apellidos" => "Tutor" ] 3 => array:2 [ "Iniciales" => "J.C." "apellidos" => "Tutor" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699511052521" "doi" => "10.3265/Nefrologia.pre2011.Jul.10893" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511052521?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411052529?idApp=UINPBA000064" "url" => "/20132514/0000003100000005/v0_201502091634/X2013251411052529/v0_201502091634/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X2013251411052545" "issn" => "20132514" "doi" => "10.3265/Nefrologia.pre2011.Jul.10834" "estado" => "S300" "fechaPublicacion" => "2011-09-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2011;31:560-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 5906 "formatos" => array:3 [ "EPUB" => 316 "HTML" => 4855 "PDF" => 735 ] ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "Serum cystatin C and microalbuminuria in the detection of vascular and renal damage in early stages a" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "560" "paginaFinal" => "566" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Cistatina C sérica y microalbuminuria en la detección del daño vascular y renal en estadios precoces, en pacientes de riesgo sin enfermedad renal crónica" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "10834_108_21681_en_t1_10834.jpg" "Alto" => 146 "Ancho" => 600 "Tamanyo" => 67413 ] ] "descripcion" => array:1 [ "en" => "Characteristics of the study population" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Juan Manuel Lopez Gomez, J.M. López Gómez, Beatriz Sacristán Enciso, B. Sacristán Enciso, María Micó, M. Micó, Fernando Arias Meneses, F. Arias Meneses, Felipe De Sande Medel, F. De Sande Medel, S. Alejo, Socorro Alejo" "autores" => array:12 [ 0 => array:2 [ "nombre" => "Juan Manuel" "apellidos" => "Lopez Gomez" ] 1 => array:2 [ "Iniciales" => "J.M." "apellidos" => "López Gómez" ] 2 => array:2 [ "nombre" => "Beatriz" "apellidos" => "Sacristán Enciso" ] 3 => array:2 [ "Iniciales" => "B." "apellidos" => "Sacristán Enciso" ] 4 => array:2 [ "nombre" => "María" "apellidos" => "Micó" ] 5 => array:2 [ "Iniciales" => "M." "apellidos" => "Micó" ] 6 => array:2 [ "nombre" => "Fernando" "apellidos" => "Arias Meneses" ] 7 => array:2 [ "Iniciales" => "F." "apellidos" => "Arias Meneses" ] 8 => array:2 [ "nombre" => "Felipe" "apellidos" => "De Sande Medel" ] 9 => array:2 [ "Iniciales" => "F." "apellidos" => "De Sande Medel" ] 10 => array:2 [ "Iniciales" => "S." "apellidos" => "Alejo" ] 11 => array:2 [ "nombre" => "Socorro" "apellidos" => "Alejo" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699511052548" "doi" => "10.3265/Nefrologia.pre2011.Jul.10834" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699511052548?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411052545?idApp=UINPBA000064" "url" => "/20132514/0000003100000005/v0_201502091634/X2013251411052545/v0_201502091634/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "titulo" => "Early diagnosis and treatment of renal cell carcinoma of native kidney in kidney transplantation" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "567" "paginaFinal" => "572" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "T. García Álvarez, A. Mazuecos Blanca, N. Navas García, L. Calle García, E. Vallejos Roca, A. Moreno Salazar, J. Soto Villalba, R. Collantes Mateos, M. Rivero Sánchez" "autores" => array:9 [ 0 => array:4 [ "Iniciales" => "T." "apellidos" => "García Álvarez" "email" => array:1 [ 0 => "teresa_garcia_alvarez@yahoo.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:3 [ "Iniciales" => "A." "apellidos" => "Mazuecos Blanca" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 2 => array:3 [ "Iniciales" => "N." "apellidos" => "Navas García" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] 3 => array:3 [ "Iniciales" => "L." "apellidos" => "Calle García" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 4 => array:3 [ "Iniciales" => "E." "apellidos" => "Vallejos Roca" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] ] ] 5 => array:3 [ "Iniciales" => "A." "apellidos" => "Moreno Salazar" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 6 => array:3 [ "Iniciales" => "J." "apellidos" => "Soto Villalba" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "affd" ] ] ] 7 => array:3 [ "Iniciales" => "R." "apellidos" => "Collantes Mateos" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 8 => array:3 [ "Iniciales" => "M." "apellidos" => "Rivero Sánchez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Servicio de Nefrología, Hospital Puerta del Mar, Cádiz, " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Servicio de Anatomía Patológica, Hospital Puerta del Mar, Cádiz, " "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] 2 => array:3 [ "entidad" => "Servicio de Radiología, Hospital Puerta del Mar, Cádiz, " "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "affc" ] 3 => array:3 [ "entidad" => "Servicio de Urología, Hospital Puerta del Mar, Cádiz, " "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "affd" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Diagnóstico y tratamiento precoz del carcinoma renal de riñón nativo en trasplante renal" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "10929_108_21884_en_t1.jpg" "Alto" => 375 "Ancho" => 600 "Tamanyo" => 159340 ] ] "descripcion" => array:1 [ "en" => "Patient characteristics" ] ] ] "textoCompleto" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">INTRODUCTION</span></p><p class="elsevierStylePara">In recent years, patient and renal graft survival has increased thanks to the introduction of new immunosuppressive drugs and better management of short and long-term complications.<span class="elsevierStyleSup">1</span> However, this increased survival, as well as the progressive increase in the average age of patients on the waiting list for kidney transplantation (KT), have increased the incidence of cancer in this population.<span class="elsevierStyleSup">1,2</span></p><p class="elsevierStylePara">One of the tumours whose incidence has increased the most is renal cell carcinoma (RCC) in native kidneys.<span class="elsevierStyleSup">3</span> Its emergence has been linked to various risk factors including immunosuppressive therapy, age, prior history of RCC and acquired cystic kidney disease (ACKD).<span class="elsevierStyleSup">3-6</span> Numerous studies confirm that tumour size at diagnosis has a significant impact on prognosis, which is much better for small tumours.<span class="elsevierStyleSup">5</span></p><p class="elsevierStylePara">Abdominal ultrasound is a simple and useful diagnostic method for early detection of these tumours. However, there is no consensus on the optimal frequency with which these examinations should be performed.<span class="elsevierStyleSup">4-7</span></p><p class="elsevierStylePara">The aim of this study was to evaluate the incidence and prognosis of RCC in KT performed in our department from January 1997 to December 2009, monitoring all patients for the development of these tumours using annual ultrasounds.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">MATERIAL AND METHOD</span></p><p class="elsevierStylePara">Since 1997, all patients who have undergone KT in our unit have been regularly monitored using a neoplasm detection protocol. As the routine detection test for RCC in native kidneys, we performed annual systematic abdominal ultrasounds in all patients undergoing KT. When the ultrasound showed lesions suspicious of RCC, we completed an abdominal computed tomography (CT) study. If the suspicion was confirmed, we proceeded to perform a nephrectomy and a histology study on the tumour. We analysed the results of 683 KT performed in our hospital from January 1997 to December 2009.</p><p class="elsevierStylePara">We collected demographic and clinical data from the patients with RCC, including age, sex, primary kidney disease, dialysis modality prior to KT, dialysis duration, number of KT, immunosuppressive treatment, time from the KT to the diagnosis of RCC and renal function at the time of the nephrectomy.</p><p class="elsevierStylePara">Regarding the diagnosis of RCC, we analysed the surgical approach and the location, size, histological type and stage of the tumour. The latter was stratified according to the international TNM classification.<span class="elsevierStyleSup">8</span> For clear cell carcinomas, the nuclear grade was classified according to the criteria proposed by Fuhrman.<span class="elsevierStyleSup">9</span></p><p class="elsevierStylePara">The coexistence of ACKD was also assessed, as well as the appearance of tumours in other locations and whether changes were made to the immunosuppressive therapy after the RCC diagnosis. Finally, we recorded patient evolution after nephrectomy, survival and renal function during follow-up, and whether there was tumour recurrence.</p><p class="elsevierStylePara">The results are expressed as median and mean ± standard deviation for quantitative variables, and as absolute and/or relative frequency for qualitative variables.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">RESULTS</span></p><p class="elsevierStylePara">Due to suspicion of RCC, 12 patients underwent 14 radical nephrectomies. In three patients, each one undergoing a unilateral nephrectomy, there were no tumours. These three patients had hepatorenal polycystic disease as their primary kidney disease. As with all cases, a pre-nephrectomy CT was performed in these three cases, with the diagnosis of cystic renal mass (Bosniak category III). Additionally, Doppler ultrasound with echo-enhancer (using sulphur hexafluoride as an IV contrast) was performed in the three cases. In two cases, the test indicated a neoplasm, but it was doubtful for the third one. Finally, nephrectomy was performed in the three cases, and the pathological diagnosis was complicated renal cysts.</p><p class="elsevierStylePara">In the nine remaining KT patients (seven unilateral nephrectomies and two bilateral nephrectomies), 11 cases of RCC were detected (five clear cell carcinomas, five papillary carcinomas and one chromophobe cell carcinoma). In one of the two bilateral nephrectomy patients, we performed a bilateral nephrectomy for bilateral RCC in the same surgical act. The other patient underwent a second nephrectomy a year after the first nephrectomy due to appearance of another RCC in the contralateral kidney.</p><p class="elsevierStylePara">In our series, the incidence of RCC in native kidneys was 1.5%. Demographic characteristics of RCC patients are shown in Table 1. At the time of tumour diagnosis, all patients except one had been on renal replacement therapy with dialysis and transplantation more than six years. There were no cases of analgesic nephropathy and only one patient had ACKD.</p><p class="elsevierStylePara">All patients received immunosuppressive therapy with mycophenolate mofetil and calcineurin inhibitors from KT. Only one patient received treatment with cyclosporine A, with the rest on tacrolimus. Three patients received induction with anti-CD25 antibodies. None of the patients had a history of acute rejection episodes. All patients were asymptomatic at the time of diagnosis, which was an accidental finding in the routine abdominal ultrasound.</p><p class="elsevierStylePara">Tumour characteristics are shown in Table 2. Radical nephrectomy was performed in all cases: seven by laparotomy (the earliest cases when laparoscopy had not yet been incorporated into our hospital) and three by laparoscopic approach. Conversion to open surgery was necessary for one patient due to complications in the laparoscopic surgery. The average tumour size was 2.6±0.45cm (range: 1.3 to 5). All tumours, except one, were less than 3.5cm in diameter. All cases of RCC were diagnosed in stage T1N0M0. The Fuhrman nuclear grade was II in the five clear cell carcinomas.  </p><p class="elsevierStylePara">Changes were made to all patients’ immunosuppressive therapy. In five patients, the calcineurin inhibitor was converted to an mTOR inhibitor, with good tolerance in all cases, except for one case where the calcineurin inhibitor had to be reintroduced due to uncontrollable oedema and proteinuria. In the remaining four cases, the use of mTOR inhibitors was contraindicated (renal failure and/or proteinuria). Therefore, immunosuppressive therapy was reduced, decreasing the dose of calcineurin inhibitor and/or mycophenolate mofetil, or discontinuing the latter.</p><p class="elsevierStylePara">After an average follow-up of 58.6±38.6 months (range: 15 to 110), all patients had excellent evolution, with 100% patient survival and no tumour recurrence. Three patients were later diagnosed with new tumours in other locations (two were diagnosed with basal cell skin carcinoma and one was diagnosed with a vesical tumour and a basal cell skin carcinoma).</p><p class="elsevierStylePara">Two patients required new inclusion in dialysis for chronic graft nephropathy, which had been diagnosed before the RCC finding. Re-inclusion in dialysis occurred at 44 and 47 months from the diagnosis of the RCC, respectively. For the other patients, renal function was optimal, with an average serum creatinine of 1.12±0.3mg/dl (range: 0.7 to 1.5) at the end of follow-up.</p><p class="elsevierStylePara"><span class="elsevierStyleBold">DISCUSSION</span></p><p class="elsevierStylePara">The increased survival of patients undergoing KT and the progressive increase in average age of patients on waiting lists for KT, has made long-term complications, such as cardiovascular disease and cancer, increasingly important in this population.<span class="elsevierStyleSup">2</span> Although cardiovascular disease is still the main cause of death for these patients, the incidence of cancer has significantly increased in recent years, especially in older recipients.<span class="elsevierStyleSup">1</span></p><p class="elsevierStylePara">In general, the risk of developing neoplasms increases for patients with chronic kidney disease. The main associated risk factors include age, previous exposure to oncogenic agents (tobacco, alcohol, sun exposure), genetic predisposition, as well as the aetiology of kidney disease, time in dialysis and uraemia-related immune dysfunction.<span class="elsevierStyleSup">2-6</span> Nevertheless, the incidence of cancer is even greater after KT, mainly due to the role of immunosuppression, along with other factors such as reactivation of viruses with oncogenic potential, age at the time of transplantation and time elapsed since transplatation.<span class="elsevierStyleSup">1-5 </span>Moreover, cancers in patients undergoing KT generally have a more aggressive nature, with more rapid progression and a poorer response to treatment.<span class="elsevierStyleSup">3,5</span></p><p class="elsevierStylePara">The most frequent tumours in the population undergoing KT are skin, genitourinary and lymphoproliferative neoplasms. Kasiske et al found that the incidence of non-melanocytic skin tumours, Kaposi's sarcoma and non-Hodgkin lymphoma was 20 times higher than in the general population.<span class="elsevierStyleSup">4</span> In recent years, an increase has also been observed in the appearance of native kidneys RCC in patients undergoing KT, for whom it is 10 to 100 times more frequent than in the general population.<span class="elsevierStyleSup">3</span> Its incidence varies significantly, between 0.3% and 4.8% depending on the series, probably because there is no agreement on how to perform diagnostic screening for this disease.<span class="elsevierStyleSup">5</span></p><p class="elsevierStylePara">Several risk factors have been associated with the appearance of RCC in the KT population, which include immunosuppressive therapy, time in dialysis, age, prior history of RCC, analgesic abuse and ACKD.<span class="elsevierStyleSup">3-6,10-13</span> In our experience, time in renal replacement therapy was prolonged in almost all cases, with a median of 31 months on dialysis before KT, and 52 months from the KT to the development of the RCC. Only one of our patients had ACKD, and it was this patient who was the longest on dialysis (82 months) before the diagnosis of RCC. This condition is considered an independent risk factor for RCC, although its absence does not rule it out,<span class="elsevierStyleSup">14</span> as we have shown in our series.</p><p class="elsevierStylePara">The course of RCC in KT is more aggressive than in the general population, with a less favourable prognosis and poorer response to treatment.<span class="elsevierStyleSup">5,15</span> Moreover, numerous studies confirm that tumour size at diagnosis has a significant impact on the evolution of the disease, and that the prognosis is much better for tumours smaller than 3cm in diameter.<span class="elsevierStyleSup">5</span> We also know that treatment in the initial stages of this disease is associated with excellent evolution, and consequently the importance of early diagnosis of this condition, especially in KT patients.<span class="elsevierStyleSup">5,16,17</span></p><p class="elsevierStylePara">Abdominal ultrasound is a simple and non-invasive diagnostic method, which is useful in detecting RCC in the native kidney of KT patients. However, the guidelines of American and European societies of nephrology and urology have not yet established how often these examinations should be performed for the early detection of RCC in native kidneys in KT.<span class="elsevierStyleSup">4-7</span> Some groups recommend performing annual ultrasound studies in asymptomatic patients, and every six months in high-risk patients.<span class="elsevierStyleSup">5,15</span> In contrast, other authors perform them every three years.<span class="elsevierStyleSup">3</span> In our experience, all patients were asymptomatic at the time of diagnosis, which was an accidental finding in the routine screening that we carry out in our unit. Annual ultrasounds allowed us to diagnose all cases very early.</p><p class="elsevierStylePara">In our study, as reported in other series,<span class="elsevierStyleSup">10,18</span> the three cases of false positive were patients with hepatorenal polycystic disease with complicated cysts (Bosniak III). This highlights the difficulty in diagnosing RCC in this disease, given that those two lesions are not always easy to distinguish. According to the Bosniak classification for renal cystic masses, stage III is at high risk of being malignant, as was the case in our patients.<span class="elsevierStyleSup">19</span> Moreover, the incidence of RCC in polycystic patients with complicated cysts may be high (up to 50%, according to Schwarz et al).<span class="elsevierStyleSup">20</span> Therefore, in patients with Bosniak III renal cysts, nephrectomy is recommended, as we eventually did in our cases.<span class="elsevierStyleSup">20,21</span></p><p class="elsevierStylePara">Among the most important prognostic factors for CCR, in addition to tumour size, are staging (TNM classification) and the Fuhrman nuclear grade.<span class="elsevierStyleSup">9,10</span> Thus, survival at five years clearly varies according to the TNM stage, with a rate of 90%-100% in stage I (T1N0M0), and less than 10% in stage IV, if distant metastases are present.<span class="elsevierStyleSup">17,22</span> According to the Fuhrman nuclear grade, RCC are divided into low (I and II) and high (III and IV) grades. In our series, the screening by ultrasound has meant that, at the time of diagnosis, the tumours were small, all in stage T1N0M0 with a low Fuhrman nuclear grade. This has definitely influenced the excellent evolution observed.</p><p class="elsevierStylePara">One patient in our series, one year after the first nephrectomy for RCC, developed another RCC in the contralateral kidney, and three other patients were diagnosed after the RCC with tumours in other locations. This suggests that these patients had a greater predisposition to developing cancer, as has been observed in other groups.<span class="elsevierStyleSup">11</span> In those patients, therefore, it is important to be especially careful during follow-up and vigilant for possible new neoplasms.</p><p class="elsevierStylePara">The link between immunosuppressive therapy and the greater risk of tumours in patients undergoing transplantation is well known.<span class="elsevierStyleSup">23</span> Calcineurin inhibitors have been associated, in general, with an increase in the incidence of cancer. One study found that this incidence is greater with tacrolimus than with cyclosporine.<span class="elsevierStyleSup">24</span> In our case, almost all patients were treated with tacrolimus, as it was the most common immunosuppressive therapy during the time period when this study was conducted. In contrast, proliferation signal inhibitors have been shown to play an antitumor role. Several studies have reported that mTOR inhibitors may be beneficial in the treatment of Kaposi's sarcoma, recurring skin cancer, renal cell carcinomas and other solid tumours.<span class="elsevierStyleSup">25-29</span> In all of our patients, we modified the immunosuppressive therapy, converting from calcineurin inhibitors to mTOR inhibitors where possible, and reducing immunosuppression for all patients. This, along with early surgical treatment of RCC, is likely to have contributed to our good results.</p><p class="elsevierStylePara">The evolution of all our patients was excellent, with a 100% survival, and without recurrence of the disease during follow-up. Although the sample size was small, our experience shows that, despite the greater incidence of RCC in KT patients, compared to the general population, the prognosis for this disease is excellent if treatment is performed in the initial stages. Therefore, annual abdominal ultrasounds should be performed in KT patients as an early detection method for RCC.</p><p class="elsevierStylePara"><a href="grande/10929_108_21884_en_t1.jpg" class="elsevierStyleCrossRefs"><img src="10929_108_21884_en_t1.jpg" alt="Patient characteristics"></img></a></p><p class="elsevierStylePara">Table 1. Patient characteristics</p><p class="elsevierStylePara"><a href="grande/10929_108_21885_en_t2.jpg" class="elsevierStyleCrossRefs"><img src="10929_108_21885_en_t2.jpg" alt="Characteristics of renal cell carcinomas"></img></a></p><p class="elsevierStylePara">Table 2. Characteristics of renal cell carcinomas</p>" "pdfFichero" => "P1-E524-S3336-A10929-EN.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:3 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec440593" "palabras" => array:1 [ 0 => "Trasplante renal" ] ] 1 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec440595" "palabras" => array:1 [ 0 => "Riñón nativo" ] ] 2 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec440597" "palabras" => array:1 [ 0 => "Carcinoma de células renales" ] ] ] "en" => array:3 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec440594" "palabras" => array:1 [ 0 => "Renal transplantation" ] ] 1 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec440596" "palabras" => array:1 [ 0 => "Native kidney" ] ] 2 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec440598" "palabras" => array:1 [ 0 => "Renal cell carcinomaRenal transplantation" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "es" => array:1 [ "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleBold">Antecedentes:</span> La frecuencia de tumores en pacientes con trasplante renal (TR) está aumentando. El carcinoma de células renales (CCR) en riñones nativos es uno de los más frecuentes y su evolución puede ser más agresiva que en la población general. <span class="elsevierStyleBold">Objetivo:</span> Evaluar la incidencia y pronóstico del CCR en los pacientes sometidoa a trasplante renal de nuestra unidad. <span class="elsevierStyleBold">Métodos:</span> Desde enero de 1997 hasta diciembre de 2009 se realizaron en nuestro hospital 683 TR. Para la detección precoz de esta patología, en todos los pacientes sometidos a trasplante realizamos una ecografía abdominal anual de forma sistemática. Los casos sospechosos se confirmaron con tomografía computarizada (TC) antes de proceder a la nefrectomía. <span class="elsevierStyleBold">Resultados:</span> Por sospecha de CCR se realizaron 14 nefrectomías radicales en 12 pacientes. En 11 nefrectomías (correspondientes a 9 pacientes), el diagnóstico anatomopatológico fue de CCR (incidencia del 1,5%).<span class="elsevierStyleBold"> </span>Todos fueron diagnosticados en estadio T1N0M0. En los tres pacientes restantes, en los que no se detectó tumor, el diagnóstico fue de quiste renal complicado en el contexto de poliquistosis hepatorrenal. En los pacientes con CCR, el tiempo en diálisis antes del diagnóstico fue de 36,7 ± 24,3 meses y el intervalo entre el TR y el diagnóstico fue de 39 ± 25,8 meses. Tras un seguimiento medio de 58,6 ± 38,6 meses, la evolución en todos ha sido excelente, sin recurrencia del tumor. <span class="elsevierStyleBold">Conclusiones:</span> La realización de ecografías anuales permite un diagnóstico precoz del CCR. El tratamiento de esta patología en estadios iniciales se asocia con un excelente pronóstico en los pacientes con TR.</p>" ] "en" => array:1 [ "resumen" => "<p class="elsevierStylePara"><span class="elsevierStyleItalic"><span class="elsevierStyleBold">Background: </span>The frecuency of malignancies in renal transplant (RT) patients is increasing. Renal cell carcinoma (RCC) of native kidneys is one of the most frequent and its outcome can be more aggressive than in general population. <span class="elsevierStyleBold">Objetive: </span>To evaluate the incidence and prognosis of RCC in renal transplant patients followed in our transplantation unit. <span class="elsevierStyleBold">Methods: </span>Between January 1997 and December 2009, 683 patients underwent kidney transplant at our hospital. Ultrasonography of the native kidneys was annually performed in all renal transplant patients. When suspect solid masses were found at ultrasonography, patients underwent computed tomography. If the suspicion was confirmed, nephrectomy was performed. <span class="elsevierStyleBold">Results: </span>14 radical nephrectomies were performed in 12 patients due to suspect CCR.  In 11 nephrectomies (corresponding to 9 patients), anatomopathologic diagnosis was CCR (incidence 1.5%). Histologic stage was T1N0M0 in all cases. In the other 3 RT, the  diagnosis was complicated renal cyst. Those patients without carcinoma had polycystic kidney disease. The time on dialysis before CCR diagnosis was  36.7 ± 24.3 months and the interval between RT and diagnosis was 39 ± 25.8 months. After a mean follow-up of  58.6 ± 38.6 months, the outcome of all cases has been excellent, without tumor recurrence. <span class="elsevierStyleBold">Conclusions:  </span>Annual renal ultrasonography plays a key role in the early diagnosis of CRR. The early treatment of this pathology is associated with an excellent prognosis in RT patients.</span></p>" ] ] "multimedia" => array:2 [ 0 => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "10929_108_21884_en_t1.jpg" "Alto" => 375 "Ancho" => 600 "Tamanyo" => 159340 ] ] "descripcion" => array:1 [ "en" => "Patient characteristics" ] ] 1 => array:8 [ "identificador" => "fig2" "etiqueta" => "Tab. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "10929_108_21885_en_t2.jpg" "Alto" => 281 "Ancho" => 600 "Tamanyo" => 159113 ] ] "descripcion" => array:1 [ "en" => "Characteristics of renal cell carcinomas" ] ] ] "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:29 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Campistol JM. Minimizing the risk of posttransplant malignancy. Transplantation 2009;87(Suppl 8):S19-22. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19384182" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Kanter J, Pallardó LM, Crespo JF, Gavela E, Beltrán S. Diagnóstico de neoplasias en una consulta de trasplante renal. Nefrologia 2009;29(4):311-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19668302" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Kasiske BL, Vazquez MA, Harmon W, Brown RS, Danovitch GM. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000;11(Suppl 15):S1-S86." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 3 => array:3 [ "identificador" => "bib4" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Kasiske BL, Snyder JJ, Gilbertson DT, Wang C.\u{A0}Cancer after kidney transplantation in the United States. Am J Transplant 2004;4(6):905-13.\u{A0} <a href="http://www.ncbi.nlm.nih.gov/pubmed/15147424" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 4 => array:3 [ "identificador" => "bib5" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Filocamo MT, Zanazzi M, Li Marzi V, Guidoni L, Villari D. Renal cell carcinoma of native kidney after renal transplantation: clinical relevance of early detection.\u{A0}Transplant Proc 2009;41(10):4197-201. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20005368" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 5 => array:3 [ "identificador" => "bib6" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "KDIGO clinical practice guideline for the care of kidney transplant recipients. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. Am\u{A0}J Transpl 2009;9(Suppl 3):S1-S155." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 6 => array:3 [ "identificador" => "bib7" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Expert Group on Renal Transplantation. European Renal Association-European Dialysis and Transplant Association. Long-term management of the transplant recipient. Nephrol Dial Transplant 2002;17(Suppl 43)." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 7 => array:3 [ "identificador" => "bib8" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL. AJCC cancer staging manual (7th ed). New York, NY: Springer; 2010." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 8 => array:3 [ "identificador" => "bib9" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Fuhrman SA, Lasky LC, Limas C. Overview of the prognosis and treatment of renal cell carcinoma. Am J Surg Pathol 1982;6(7):655-63. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7180965" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 9 => array:3 [ "identificador" => "bib10" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Tillou X, Dermailly M, Hakami F, Westeel PF, Saint F. De novo renal carcinoma in renal transplant recipients: effect of early treatment. Transplant Proc 2009;41(8):3314-6. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19857739" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 10 => array:3 [ "identificador" => "bib11" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Szmidt J, Durlik M, Galazka Z, Nazarewski S, Górnicka B. Low-stage renal carcinoma of the native kidney in renal transplant recipients. Transplant Proc 2002;34(2):583-4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12009631" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 11 => array:3 [ "identificador" => "bib12" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Goh A, Vathsala A. Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am J Transpl 2011;11(1):86-92." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 12 => array:3 [ "identificador" => "bib13" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Shapiro R, Kaplan B. Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am\u{A0}J Transpl 2011;11(1):10.\u{A0}" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 13 => array:3 [ "identificador" => "bib14" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Doublet JD, Peraldi MN, Gattegno B, Thibault P, Sraer JD. Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients. J Urol 1997;158(1):42-4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9186319" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 14 => array:3 [ "identificador" => "bib15" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Neuzillet Y, Lay F, Luccioni A, Daniel L, Berland Y. De novo renal cell carcinoma of native kidney in renal transplant recipients. Cancer 2005;103(2):251-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15593084" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 15 => array:3 [ "identificador" => "bib16" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Ianhez LE, Lucon M, Nahas WC, Sabbaga E, Saldanha LB. Renal cell carcinoma in renal transplant patients. Urology 2007;69(3):462-4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17382145" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 16 => array:3 [ "identificador" => "bib17" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM. Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort. J Urol 2005;173(6):1889-92. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15879769" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 17 => array:3 [ "identificador" => "bib18" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Sasagawa I, Terasawa Y, Ishizaki M, Takahashi H, Suzuki K, Imai K,\u{A0}et al. Comparison of ultrasonography, computerized tomography and angiography in dialysis patients with renal cell carcinoma. Urol Int 1992;49:206. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1475861" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 18 => array:3 [ "identificador" => "bib19" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Israel GM, Bosniak MA. An update of the Bosniak renal cyst classification system. Urology 2005;66:484-8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16140062" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 19 => array:3 [ "identificador" => "bib20" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Schawarz A, Vatandaslar S. Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol\u{A0}2007;2:750-6." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 20 => array:3 [ "identificador" => "bib21" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Scandling J. Acquired cystic kidney disease and renal cell ancer after transplantation: time to rethink screening? Clin J Am Soc Nephrol\u{A0}2007;2:621-2." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 21 => array:3 [ "identificador" => "bib22" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Mekhail TM, Abou-Jawde RM, Boumerhi G, Malgi S, Wood L. Validation and extension of the memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. J Clin Oncol 2005;23(4):832-41. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15681528" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 22 => array:3 [ "identificador" => "bib23" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Rama I, Grinyó JM. Malignancy after renal transplantation: the role of immunosupression. Nat Rev Nephrol 2010;6(9):511-9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20736984" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 23 => array:3 [ "identificador" => "bib24" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Navarro MD, López-Andreu M, Rodríguez-Benot A, Agüera ML, Del Castillo D. Cancer incidence and survival in kidney transplant patients. Transplant Proc 2008;40(9):2936-40. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19010153" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:1 [ "itemHostRev" => array:3 [ "pii" => "S0140673602093273" "estado" => "S300" "issn" => "01406736" ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib25" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Garnock-Jones KP, Keating GM. Everolimus: in advanced renal cell carcinoma. Drugs 2009;69(15):2115-24. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19791829" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 25 => array:3 [ "identificador" => "bib26" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Ruangkanchanasetr P, Kanjanapayak B, Jungmeechoke K. Prolonged survival in renal transplant recipient with advanced renal cell carcinoma by everolimus and sorafenib. Nephrology (Carlton) 2011;16(1):118-9." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 26 => array:3 [ "identificador" => "bib27" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Campistol J, Albanell J, Arns W, Boletis I, Dantal J. Use of proliferation signal inhibitors in the management of post-transplant malignancies-clinical guidance. Neprol Dial Transplant 2007;22(Suppl 1):i36-41." "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:1 [ "itemHostRev" => array:3 [ "pii" => "S0735109708021219" "estado" => "S300" "issn" => "07351097" ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib28" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Reddy GK, Mughal TI, Rini BI. Current data with mammalian target of rapamycin inhibitors in advanced-stage renal cell carcinoma. Clin Genitourin Cancer 2006;5(2):110-3. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17026798" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 28 => array:3 [ "identificador" => "bib29" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Hernández D, Martínez D, Gutiérrez E, López V, Gutiérrez C. Evidencias clínicas sobre el uso de los fármacos anti-mTOR en el trasplante renal. Nefrologia 2011;31(1):27-34. <a href="http://www.ncbi.nlm.nih.gov/pubmed/21270910" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000003100000005/v0_201502091634/X2013251411052537/v0_201502091634/en/main.assets" "Apartado" => array:4 [ "identificador" => "35441" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Originals" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003100000005/v0_201502091634/X2013251411052537/v0_201502091634/en/P1-E524-S3336-A10929-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251411052537?idApp=UINPBA000064" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 7 | 7 | 14 |
| 2024 October | 52 | 39 | 91 |
| 2024 September | 50 | 37 | 87 |
| 2024 August | 78 | 57 | 135 |
| 2024 July | 54 | 46 | 100 |
| 2024 June | 104 | 55 | 159 |
| 2024 May | 83 | 38 | 121 |
| 2024 April | 67 | 32 | 99 |
| 2024 March | 60 | 24 | 84 |
| 2024 February | 56 | 35 | 91 |
| 2024 January | 67 | 31 | 98 |
| 2023 December | 48 | 28 | 76 |
| 2023 November | 62 | 30 | 92 |
| 2023 October | 54 | 49 | 103 |
| 2023 September | 53 | 37 | 90 |
| 2023 August | 45 | 25 | 70 |
| 2023 July | 56 | 24 | 80 |
| 2023 June | 45 | 29 | 74 |
| 2023 May | 37 | 31 | 68 |
| 2023 April | 46 | 16 | 62 |
| 2023 March | 33 | 29 | 62 |
| 2023 February | 48 | 38 | 86 |
| 2023 January | 53 | 27 | 80 |
| 2022 December | 61 | 32 | 93 |
| 2022 November | 49 | 50 | 99 |
| 2022 October | 56 | 57 | 113 |
| 2022 September | 64 | 43 | 107 |
| 2022 August | 38 | 55 | 93 |
| 2022 July | 36 | 51 | 87 |
| 2022 June | 42 | 42 | 84 |
| 2022 May | 44 | 32 | 76 |
| 2022 April | 63 | 52 | 115 |
| 2022 March | 46 | 58 | 104 |
| 2022 February | 58 | 46 | 104 |
| 2022 January | 41 | 30 | 71 |
| 2021 December | 52 | 55 | 107 |
| 2021 November | 41 | 36 | 77 |
| 2021 October | 53 | 50 | 103 |
| 2021 September | 36 | 34 | 70 |
| 2021 August | 41 | 45 | 86 |
| 2021 July | 45 | 42 | 87 |
| 2021 June | 66 | 30 | 96 |
| 2021 May | 76 | 44 | 120 |
| 2021 April | 120 | 56 | 176 |
| 2021 March | 102 | 41 | 143 |
| 2021 February | 77 | 26 | 103 |
| 2021 January | 82 | 25 | 107 |
| 2020 December | 134 | 19 | 153 |
| 2020 November | 52 | 28 | 80 |
| 2020 October | 57 | 17 | 74 |
| 2020 September | 47 | 8 | 55 |
| 2020 August | 55 | 15 | 70 |
| 2020 July | 50 | 6 | 56 |
| 2020 June | 47 | 24 | 71 |
| 2020 May | 56 | 30 | 86 |
| 2020 April | 54 | 20 | 74 |
| 2020 March | 63 | 13 | 76 |
| 2020 February | 70 | 32 | 102 |
| 2020 January | 91 | 27 | 118 |
| 2019 December | 87 | 18 | 105 |
| 2019 November | 69 | 24 | 93 |
| 2019 October | 63 | 13 | 76 |
| 2019 September | 88 | 27 | 115 |
| 2019 August | 54 | 8 | 62 |
| 2019 July | 55 | 26 | 81 |
| 2019 June | 43 | 10 | 53 |
| 2019 May | 44 | 22 | 66 |
| 2019 April | 100 | 36 | 136 |
| 2019 March | 38 | 19 | 57 |
| 2019 February | 33 | 15 | 48 |
| 2019 January | 51 | 19 | 70 |
| 2018 December | 111 | 41 | 152 |
| 2018 November | 96 | 24 | 120 |
| 2018 October | 110 | 16 | 126 |
| 2018 September | 91 | 17 | 108 |
| 2018 August | 64 | 23 | 87 |
| 2018 July | 55 | 14 | 69 |
| 2018 June | 48 | 15 | 63 |
| 2018 May | 62 | 20 | 82 |
| 2018 April | 61 | 7 | 68 |
| 2018 March | 90 | 8 | 98 |
| 2018 February | 74 | 4 | 78 |
| 2018 January | 75 | 9 | 84 |
| 2017 December | 58 | 8 | 66 |
| 2017 November | 65 | 18 | 83 |
| 2017 October | 54 | 8 | 62 |
| 2017 September | 55 | 17 | 72 |
| 2017 August | 48 | 12 | 60 |
| 2017 July | 44 | 10 | 54 |
| 2017 June | 63 | 11 | 74 |
| 2017 May | 67 | 8 | 75 |
| 2017 April | 48 | 24 | 72 |
| 2017 March | 31 | 22 | 53 |
| 2017 February | 49 | 14 | 63 |
| 2017 January | 36 | 9 | 45 |
| 2016 December | 66 | 12 | 78 |
| 2016 November | 73 | 5 | 78 |
| 2016 October | 91 | 12 | 103 |
| 2016 September | 145 | 12 | 157 |
| 2016 August | 209 | 6 | 215 |
| 2016 July | 187 | 5 | 192 |
| 2016 June | 144 | 0 | 144 |
| 2016 May | 136 | 0 | 136 |
| 2016 April | 110 | 0 | 110 |
| 2016 March | 85 | 0 | 85 |
| 2016 February | 119 | 0 | 119 |
| 2016 January | 107 | 0 | 107 |
| 2015 December | 95 | 0 | 95 |
| 2015 November | 87 | 0 | 87 |
| 2015 October | 88 | 0 | 88 |
| 2015 September | 79 | 0 | 79 |
| 2015 August | 75 | 0 | 75 |
| 2015 July | 78 | 0 | 78 |
| 2015 June | 41 | 0 | 41 |
| 2015 May | 56 | 0 | 56 |
| 2015 April | 5 | 0 | 5 |
Show all
